Internal medicine

Cohort study

Respiratory failure

Disease

Extracorporeal

Life support

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Outbreak

Intensive care medicine

Virology

Emergency medicine

Extracorporeal membrane oxygenation

Mechanical ventilation

Acute respiratory failure

2019-20 coronavirus outbreak

Cohort

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Medicine

The Lancet

In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were less than 40%. These data from 213 hospitals worldwide provide a generalisable estimate of ECMO mortality in the setting of COVID-19.

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry